Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher (TMO) Strategic Buyouts Aid Amid Macro Issues
Thermo Fisher's (TMO) business strategy primarily includes expansion through strategic acquisition of technologies and businesses that augment the company's existing products and services.
Thermo Fisher (TMO) Brings Biobased, Sustainable Films for BPCs
Thermo Fisher (TMO) has launched biobased solutions to help reduce the climate impact on the manufacturing of therapies.
Thermo Fisher (TMO) Expands Central Lab Footprint in Kentucky
Thermo Fisher (TMO) announces expansion of its central laboratory operations in Kentucky. The new space in Covington will be in addition to its existing central lab in Highland Heights.
Thermo Fisher's (TMO) New Launch Speeds Up pDNA Purification
Thermo Fisher (TMO) introduces the Thermo Scientific KingFisher PlasmidPro, the fully automated maxi-scale pDNA purification system.
Thermo Fisher (TMO) Unveils New Research Laboratory in WI
Thermo Fisher Scientific Inc. TMO has announced a new clinical research laboratory building at its good manufacturing practices (GMP) lab in Middleton, WI, under its PPD clinical research business.
Thermo Fisher's (TMO) New Buyouts Aid Growth, FX Issues Stay
Thermo Fisher's (TMO) business strategy primarily includes expansion through strategic acquisition of technologies and businesses that augment the company's existing products and services.
Thermo Fisher's (TMO) New Launch Supports Full Lab Automation
Thermo Fisher's (TMO) first-of-its-kind innovation for CO2 incubators supports emerging automated cell therapy production processes.
Here's Why Thermo Fisher (TMO) Should be in Your Portfolio
Strategic alliances and impressive product launches bode well for Thermo Fisher (TMO).
Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends
Thermo Fisher Scientific is well-positioned to benefit from the demand for innovation in the healthcare and biotech sectors. The company's strategic acquisitions have improved its growth capabilities and deepened its relationships with biopharma partners. Despite a low dividend yield, TMO has a history of strong total returns and consistent dividend growth, making it a compelling long-term investment.
Thermo Fisher (TMO) Up 2.3% Since Last Earnings Report: Can It Continue?
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
Thermo Fisher (TMO) Unveils New Extended Blood Genotyping Array
Thermo Fisher's (TMO) new Applied Biosystems Axiom BloodGenomiX Array and Software provide a high-throughput solution for more precise blood matching research.
